Novel PARP1/2 inhibitor mefuparib hydrochloride elicits potent <i>in vitro</i> and <i>in vivo</i> anticancer activity, characteristic of high tissue distribution
Jin‐Xue He(Chinese Academy of Sciences), Ze‐Hong Miao(Nanchang University)
Cited by 41
Related Papers
An integrative drug repositioning framework discovered a potential therapeutic agent targeting COVID-19
|Signal Transduction and Targeted Therapy|2021|204
A data-driven drug repositioning framework discovered a potential therapeutic agent targeting COVID-19
|bioRxiv (Cold Spring Harbor Laboratory)|2020|168
Dual targeting of microtubule and topoisomerase II by α-carboline derivative YCH337 for tumor proliferation and growth inhibition
|Oncotarget|2015|52
Hypoxia induces universal but differential drug resistance and impairs anticancer mechanisms of 5-fluorouracil in hepatoma cells
|Acta Pharmacologica Sinica|2017|46